Verve Ventures interview with CEO Karsten Lindhardt

Interview Karsten Lindhardt: “We are uniquely positioned to succeed” (verve.vc)

The use of injections in treatments is widespread, but their use can become a burden to patients and severely impact their quality of life. Biograil™ is working on an innovative delivery mechanism for biological drugs that could offer a valuable alternative to injections.

In this interview, Karsten Lindhardt, the company’s CEO and founder, reveals how Biograil’s extensive experience, strategic partnerships and innovative approach will help them deliver and scale a market-ready product that will transform drug delivery and improve the lives of patients worldwide.